LDS/Medical Tests/TGFBI Gene Mutation Analysis

TGFBI Gene Mutation Analysis

The TGFBI gene is located in the long (q) arm of chromosome 5 at position 31.1 and encodes transforming growth factor beta-induced protein. Transforming growth factor β induced (TGFBI; originally known as βig-h3, or keratoepithelin) is a transforming growth factor β (TGF-β1 and TGF-β2)–inducible, secreted extracellular matrix protein expressed ubiquitously in most tissues, except brain. This protein contains an N terminal secretory signal peptide, a cysteine-rich domain (EMI), four consecutive fasciclin 1 (FAS) repeats, and a C-terminal Arg-Gly-Asp (RGD) integrin-binding motif. The protein may participate in many processes, including morphogenesis, adhesion/migration, corneal dystrophy, tumorigenesis, wound healing, and inflammation.

TGFBI gene mutations are involved in a number of corneal dystrophy, including: Lattice corneal dystrophy type 1 (CDL1), Groenouw corneal dystrophy, Avellino corneal dystrophy, lattice corneal dystrophy type IIIA, Reis-Bucklers corneal dystrophy, Thiel-Behnke corneal dystrophy, and epithelial basement membrane corneal dystrophy. All of these are characterized by an accumulation of amyloid material in the cornea, leading to impaired vision. The amyloid deposits form in various shapes and patterns and occur in different layers of the cornea, which define the different types of corneal dystrophies. The gene mutations that cause these conditions change single amino acids in the TGFBI protein.

Lattice corneal dystrophy type I is an autosomal dominant condition characterized by vision impairment and painful corneal erosions due to poor epithelial adhesion. Onset occurs in the first or second decade of life and progresses over time. The anterior, central corneal stroma contains rod-like or linear opacities leaving a relatively normal periphery. The mutation replaces the amino acid arginine with the amino acid cysteine at position 124 (written as Arg124Cys or R124C).

In Avellino corneal dystrophy the mutation that replaces the amino acid arginine at position 124 with the amino acid histidine (written as Arg124His). In Reis-Bucklers the same amino acid is replaced with lysine (written as Arg124Lys). Likewise, the mutation that replaces the amino acid arginine at position 555 with the amino acid glutamine (written as Arg555Gln) and tryptophan (written as Arg555Trp) most often causes Thiel-Behnke corneal dystrophy and Groenouw corneal dystrophy respectively.

Lastly, it has been shown that TGFBI serves as an anti-adhesive protein that regulates the invasive growth of melanoma, which in addition to other melanoma markers can be used for the diagnosis and management of melanoma.

  • As an aid in diagnosis of TGFBI-associated corneal dystrophy
  • This gene is part of the genetic panel for diagnosis of melanoma
  • Carrier screening in family members at high risk
  • For the prenatal and preimplantation genetic test in an individual at risk of corneal dystrophy
  • To assist with prognosis, clinical management and surveillance for disease features based on the genetic variant involved
Mutation or pathogenic variant in TGFBI gene. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants.

Negative for mutations or pathogenic variants in TGFBI gene

Sequence analysis by next generation sequencing or bi-directional sequencing. TGFBI gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.

Whole blood (EDTA), amniotic fluid (prenatal test).

Stability

  • Ambient: 72 hours
  • Refrigerated: 1 week
  • Frozen: Unacceptable
Genetic Corneal Dystrophy Panel, Methylation specific PCR for specific genes.
1-2 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login